含有水性超分子烯复合物的水凝,用于促进糖尿病慢性伤口愈合
Yue Wang1, Hui Fang2, Guofeng Zhou1
1Department of Cardiology, Zibo Central Hospital, NO.10, South Shanghai Road, Zibo, 255000, China.
Materials today. Bio
|September 22, 2025
概括
这项研究提出了一种新型抗氧化剂水凝 (6HPB@C60凝),可以加速糖尿病伤口愈合. 凝有效降低氧化应激和炎症,促进更快的关闭和改善伤口质量.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 由于过度的氧化应激,糖尿病会影响慢性伤口愈合.
- 需要新的抗氧化剂系统来应对这一临床挑战.
研究的目的:
- 开发和评估一种水溶性富勒烯C60基抗氧化剂水凝,用于糖尿病伤口愈合.
- 研究6HPB@C60凝在加速伤口关闭和改善组织再生方面的有效性.
主要方法:
- 在6HPB超分子中封装富勒C60以创建水溶性复合物 (6HPB@C60).
- 将6HPB@C60加载到甲基酸盐水凝中,形成一个抗氧化系统 (6HPB@C60凝).
- 在糖尿病模型中评估水凝的微观结构,组织粘附性,细胞毒性,抗氧化能力和体内伤口愈合性能.
主要成果:
- 6HPB@C60凝表现出优异的抗氧化能力,组织粘附性和低细胞毒性.
- 用6HPB@C60凝治疗的糖尿病慢性伤口表现出加速愈合,其特点是减少活性氧物种,调节巨细胞极化,增强细胞增殖,上皮化和原沉积.
- 水凝连续消除了反应性氧物种,减少了促炎症状态.
结论:
- 开发的6HPB@C60凝代表了一种有前途的抗氧化疗法,用于治疗糖尿病慢性伤口.
- 这种新型水凝显著加速糖尿病伤口的关闭,并提高整体伤口质量,为临床应用提供了潜在的解决方案.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...


